Its powerful effect achieves bactericidal action at a minimum concentration and in a shorter period of time Tylvax has a powerful mycoplasmicide effect: ten times higher than tylosin.

Recently the European Medicines Agency (EMA) established new maximum residue limits for Tilvalosina allowed in hens' eggs for human consumption, concluding that "no withdrawal period in production" should be applied.

Tylvalosin has shown to have a very fast absorption. In just 30 to 60 minutes (chickens and pigs respectively) it reaches therapeutic plasmatic levels. In comparison, tylosin requires twice as long to achieve lower levels.

Tylvax is highly effective against respiratory and enteric pathogens, accumulating in the tissues in a selective way, reaching pulmonary and mucosal lining concentrations higher than plasmatic concentration. Also, by concentrating in bile, it guarantees its presence in the digestive tract against enteric pathogens.

Tylvalosin present in Tylvax binds to bacterial ribosome, preventing the development of protein synthesis, thereby causing inhibition of bacterial growth or death. In addition, the main metabolite binds to another receptor of the bacterial ribosome, ensuring powerful action.

Ideal growth promoter, improves conversion rates and production efficiency.

Tylvalosin rapidly reaches high intracellular concentrations. Similarly, if the concentration in the extracellular environment is lower than in the intracellular space, the drug is released from inside of the cell, enhancing the antibacterial action both intracellular and extracellularly.

Tylvax can increase the activity of macrophages, helping the non-specific immune system to remove pathogen agents. Tylvalosin makes macrophages more active and stimulates the differentiation of monocytes to macrophages.